A five-year review of chemoradiotherapy practice in anal cancer: Radiotherapy audit results from a cancer centre in Wales, UK
To review a five-year clinical practice of radical chemoradiotherapy (CRT) for anal cancers at a cancer centre in Wales.
Management of cancer treatment–induced bone loss in patients with breast and hormone sensitive prostate cancer: AIOM survey
Cancer treatment–induced bone loss is a side effect of hormonal therapy that can severely affect patients’ quality of life. The aim of this survey was to obtain an updated picture of management of bone health in patients with breast cancer undergoing adjuvant hormonal therapy and in patients with hormone sensitive prostate cancer according to Italian oncologists.